vs

Side-by-side financial comparison of Arcosa, Inc. (ACA) and Calumet, Inc. (CLMT). Click either name above to swap in a different company.

Calumet, Inc. is the larger business by last-quarter revenue ($1.0B vs $716.7M, roughly 1.4× Arcosa, Inc.). Arcosa, Inc. runs the higher net margin — 7.3% vs -3.6%, a 10.9% gap on every dollar of revenue. Calumet, Inc. produced more free cash flow last quarter ($103.8M vs $55.8M).

Arcosa, Inc. is a provider of infrastructure-related products and solutions operating across three core segments: construction, energy, and transportation. It offers products including utility structures, construction aggregates, and transportation components, primarily serving customers across the North American market to support critical infrastructure development projects.

Calumet, Inc. is a U.S.-headquartered specialty products firm that manufactures and distributes high-value hydrocarbon and specialty chemical products. Its offerings include specialty oils, lubricants, waxes, and renewable fuel solutions, serving industrial, consumer, and transportation segments across North America.

ACA vs CLMT — Head-to-Head

Bigger by revenue
CLMT
CLMT
1.4× larger
CLMT
$1.0B
$716.7M
ACA
Higher net margin
ACA
ACA
10.9% more per $
ACA
7.3%
-3.6%
CLMT
More free cash flow
CLMT
CLMT
$48.0M more FCF
CLMT
$103.8M
$55.8M
ACA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACA
ACA
CLMT
CLMT
Revenue
$716.7M
$1.0B
Net Profit
$52.1M
$-37.3M
Gross Margin
22.9%
-0.3%
Operating Margin
11.0%
-6.2%
Net Margin
7.3%
-3.6%
Revenue YoY
7.6%
Net Profit YoY
776.6%
EPS (diluted)
$1.06
$-0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACA
ACA
CLMT
CLMT
Q4 25
$716.7M
$1.0B
Q3 25
$797.8M
$1.1B
Q2 25
$736.9M
$1.0B
Q1 25
$632.0M
$993.9M
Q4 24
$666.2M
Q3 24
$640.4M
$1.1B
Q2 24
$664.7M
$1.1B
Q1 24
$598.6M
Net Profit
ACA
ACA
CLMT
CLMT
Q4 25
$52.1M
$-37.3M
Q3 25
$73.0M
$313.4M
Q2 25
$59.7M
$-147.9M
Q1 25
$23.6M
$-162.0M
Q4 24
$-7.7M
Q3 24
$16.6M
$-100.6M
Q2 24
$45.6M
$-39.1M
Q1 24
$39.2M
Gross Margin
ACA
ACA
CLMT
CLMT
Q4 25
22.9%
-0.3%
Q3 25
24.1%
34.7%
Q2 25
22.5%
-4.2%
Q1 25
19.8%
-8.2%
Q4 24
19.3%
Q3 24
21.3%
0.4%
Q2 24
20.8%
5.6%
Q1 24
18.6%
Operating Margin
ACA
ACA
CLMT
CLMT
Q4 25
11.0%
-6.2%
Q3 25
14.1%
30.0%
Q2 25
12.9%
-9.8%
Q1 25
8.8%
-4.9%
Q4 24
6.5%
Q3 24
5.3%
-5.2%
Q2 24
10.1%
0.5%
Q1 24
8.9%
Net Margin
ACA
ACA
CLMT
CLMT
Q4 25
7.3%
-3.6%
Q3 25
9.2%
29.1%
Q2 25
8.1%
-14.4%
Q1 25
3.7%
-16.3%
Q4 24
-1.2%
Q3 24
2.6%
-9.1%
Q2 24
6.9%
-3.4%
Q1 24
6.5%
EPS (diluted)
ACA
ACA
CLMT
CLMT
Q4 25
$1.06
$-0.43
Q3 25
$1.48
$3.61
Q2 25
$1.22
$-1.70
Q1 25
$0.48
$-1.87
Q4 24
$-0.16
Q3 24
$0.34
$-1.18
Q2 24
$0.93
$-0.48
Q1 24
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACA
ACA
CLMT
CLMT
Cash + ST InvestmentsLiquidity on hand
$214.6M
$125.1M
Total DebtLower is stronger
$1.5B
$2.1B
Stockholders' EquityBook value
$2.6B
$-732.7M
Total Assets
$5.0B
$2.7B
Debt / EquityLower = less leverage
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACA
ACA
CLMT
CLMT
Q4 25
$214.6M
$125.1M
Q3 25
$220.0M
$94.6M
Q2 25
$189.7M
$110.6M
Q1 25
$167.9M
$123.4M
Q4 24
$187.3M
Q3 24
$756.8M
$34.6M
Q2 24
$103.7M
$7.0M
Q1 24
$176.5M
Total Debt
ACA
ACA
CLMT
CLMT
Q4 25
$1.5B
$2.1B
Q3 25
$1.6B
$2.1B
Q2 25
$1.7B
$2.1B
Q1 25
$1.7B
$2.3B
Q4 24
$1.7B
Q3 24
$1.2B
$1.7B
Q2 24
$699.9M
Q1 24
$600.6M
Stockholders' Equity
ACA
ACA
CLMT
CLMT
Q4 25
$2.6B
$-732.7M
Q3 25
$2.6B
$-695.3M
Q2 25
$2.5B
$-1.0B
Q1 25
$2.5B
$-862.3M
Q4 24
$2.4B
Q3 24
$2.4B
$-672.2M
Q2 24
$2.4B
$-566.4M
Q1 24
$2.4B
Total Assets
ACA
ACA
CLMT
CLMT
Q4 25
$5.0B
$2.7B
Q3 25
$5.1B
$2.7B
Q2 25
$5.0B
$2.8B
Q1 25
$4.9B
$2.8B
Q4 24
$4.9B
Q3 24
$4.4B
$2.6B
Q2 24
$3.8B
$100
Q1 24
$3.7B
Debt / Equity
ACA
ACA
CLMT
CLMT
Q4 25
0.57×
Q3 25
0.61×
Q2 25
0.67×
Q1 25
0.68×
Q4 24
0.69×
Q3 24
0.51×
Q2 24
0.29×
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACA
ACA
CLMT
CLMT
Operating Cash FlowLast quarter
$120.0M
$116.5M
Free Cash FlowOCF − Capex
$55.8M
$103.8M
FCF MarginFCF / Revenue
7.8%
10.0%
Capex IntensityCapex / Revenue
9.0%
1.2%
Cash ConversionOCF / Net Profit
2.30×
TTM Free Cash FlowTrailing 4 quarters
$175.5M
$56.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACA
ACA
CLMT
CLMT
Q4 25
$120.0M
$116.5M
Q3 25
$160.6M
$23.5M
Q2 25
$61.2M
$-1.8M
Q1 25
$-700.0K
$-29.3M
Q4 24
$248.2M
Q3 24
$135.0M
$-15.5M
Q2 24
$38.3M
Q1 24
$80.5M
Free Cash Flow
ACA
ACA
CLMT
CLMT
Q4 25
$55.8M
$103.8M
Q3 25
$121.0M
$15.1M
Q2 25
$33.4M
$-15.4M
Q1 25
$-34.7M
$-46.9M
Q4 24
$194.9M
Q3 24
$100.6M
$-32.2M
Q2 24
$-9.3M
Q1 24
$26.1M
FCF Margin
ACA
ACA
CLMT
CLMT
Q4 25
7.8%
10.0%
Q3 25
15.2%
1.4%
Q2 25
4.5%
-1.5%
Q1 25
-5.5%
-4.7%
Q4 24
29.3%
Q3 24
15.7%
-2.9%
Q2 24
-1.4%
Q1 24
4.4%
Capex Intensity
ACA
ACA
CLMT
CLMT
Q4 25
9.0%
1.2%
Q3 25
5.0%
0.8%
Q2 25
3.8%
1.3%
Q1 25
5.4%
1.8%
Q4 24
8.0%
Q3 24
5.4%
1.5%
Q2 24
7.2%
2.2%
Q1 24
9.1%
Cash Conversion
ACA
ACA
CLMT
CLMT
Q4 25
2.30×
Q3 25
2.20×
0.07×
Q2 25
1.03×
Q1 25
-0.03×
Q4 24
Q3 24
8.13×
Q2 24
0.84×
Q1 24
2.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACA
ACA

Engineered Structures$301.1M42%
Total Construction Materials$276.8M39%
Specialty Materials And Asphalt$110.2M15%
Construction Site Support$28.6M4%

CLMT
CLMT

Specialty Products And Solutions$675.9M65%
Montana Renewables$294.2M28%
Performance Brands$68.5M7%

Related Comparisons